Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...

Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.

By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...

The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...

Yet another biotech is facing a delay from the FDA as the agency reels from intense staffing cuts. | Yet another biotech is ...

A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting ...

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.

A new brain-computer interface can decode a person's inner speech, which could help people with paralysis communicate.

ROME, AUG 19 - An Italo-US team of scientists have made a breakthrough in the early diagnosis of amyotrophic lateral ...

SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...

A patient with amyotrophic lateral sclerosis (ALS) has become the first person in the world to control an iPad entirely by ...